Search research articles
Contact Us
Filters
Showing results (241-250 of 257) with videos related to
Page
of 26
Sort By:
European Radiology
|
December 7, 2023
Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee
Aart J van der Molen, Johannes G Krabbe, Ilona A Dekkers, et al.
Ebiomedicine
|
November 28, 2025
Quantitative susceptibility mapping at 7T as a biomarker of post- and interictal extravascular iron in patients with focal epilepsy
Nina Rebecca Held, Tobias Bauer, Rüdiger Stirnberg, et al.
Neuro-Oncology
|
October 1, 2024
Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide
Thomas Zeyen, Laura Böhm, Daniel Paech, et al.
The Lancet. Oncology
|
April 7, 2019
Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study
Philipp Kickingereder, Fabian Isensee, Irada Tursunova, et al.
Nature Neuroscience
|
October 14, 2025
Region-specific drivers of CSF mobility measured with MRI in humans
Lydiane Hirschler, Bobby A Runderkamp, Andreas Decker, et al.
Journal of Neurology
|
August 14, 2024
Rasmussen's encephalitis: structural, functional, and clinical correlates of contralesional epileptiform activity
Tobias Bauer, Randi D von Wrede, Suresh Pujar, et al.
Journal of Stroke
|
February 18, 2021
Safety and Angiographic Efficacy of Intra-Arterial Fibrinolytics as Adjunct to Mechanical Thrombectomy: Results from the INFINITY Registry
Johannes Kaesmacher, Nuran Abdullayev, Basel Maamari, et al.
Trials
|
January 20, 2022
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial
Thomas Zeyen, Anna-Laura Potthoff, Robert Nemeth, et al.
The Lancet. Oncology
|
February 29, 2024
Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort study
Aditya Rastogi, Gianluca Brugnara, Martha Foltyn-Dumitru, et al.
Stroke
|
March 3, 2020
Does Device Selection Impact Recanalization Rate and Neurological Outcome?: An Analysis of the Save ChildS Study
Peter B Sporns, Ronald Straeter, Jens Minnerup, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 257) with videos related to
Sort By:
Page
of 26
European Radiology
|
December 7, 2023
Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee
Aart J van der Molen, Johannes G Krabbe, Ilona A Dekkers, et al.
Ebiomedicine
|
November 28, 2025
Quantitative susceptibility mapping at 7T as a biomarker of post- and interictal extravascular iron in patients with focal epilepsy
Nina Rebecca Held, Tobias Bauer, Rüdiger Stirnberg, et al.
Neuro-Oncology
|
October 1, 2024
Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide
Thomas Zeyen, Laura Böhm, Daniel Paech, et al.
The Lancet. Oncology
|
April 7, 2019
Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study
Philipp Kickingereder, Fabian Isensee, Irada Tursunova, et al.
Nature Neuroscience
|
October 14, 2025
Region-specific drivers of CSF mobility measured with MRI in humans
Lydiane Hirschler, Bobby A Runderkamp, Andreas Decker, et al.
Journal of Neurology
|
August 14, 2024
Rasmussen's encephalitis: structural, functional, and clinical correlates of contralesional epileptiform activity
Tobias Bauer, Randi D von Wrede, Suresh Pujar, et al.
Journal of Stroke
|
February 18, 2021
Safety and Angiographic Efficacy of Intra-Arterial Fibrinolytics as Adjunct to Mechanical Thrombectomy: Results from the INFINITY Registry
Johannes Kaesmacher, Nuran Abdullayev, Basel Maamari, et al.
Trials
|
January 20, 2022
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial
Thomas Zeyen, Anna-Laura Potthoff, Robert Nemeth, et al.
The Lancet. Oncology
|
February 29, 2024
Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort study
Aditya Rastogi, Gianluca Brugnara, Martha Foltyn-Dumitru, et al.
Stroke
|
March 3, 2020
Does Device Selection Impact Recanalization Rate and Neurological Outcome?: An Analysis of the Save ChildS Study
Peter B Sporns, Ronald Straeter, Jens Minnerup, et al.
Page
of 26